C-reactive protein predicts functional status and correlates with left ventricular ejection fraction in patients with chronic stable angina

Atherosclerosis

Volumn 205, Issue 1, 2009, Pages 319-324

  Arroyo Espliguero, Ramón ^a   Avanzas, Pablo ^b   Quiles, Juan ^c   Kaski, Juan Carlos ^d  

^a HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

C reactive protein; Chronic stable angina; Heart failure; Inflammation; Left ventricular ejection fraction; NYHA functional class

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STABLE ANGINA PECTORIS;

AGED; ANGINA PECTORIS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 67349097393     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.018     Document Type: Article

References (28)

1. Mann D.L. Recent insights into the role of tumor necrosis factor in the failing heart. Heart Fail Rev 6 (2001) 71-80
2. Wollert K.C., and Drexler H. The role of interleukin-6 in the failing heart. Heart Fail Rev 6 (2001) 95-103
3. Torre-Amione G., Kapadia S., Benedict C., et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol 27 (1996) 1201-1206
4. Bozkurt B., Kribbs S., Clubb F.J., et al. Pathophysiology relevant concentrations of tumor necrosis factor-α promote progressive left ventricular dysfunction and remodeling in rats. Circulation 97 (1998) 1382-1391
5. Murray D.R., and Freeman G.L. Tumor necrosis factor-α induces a biphasic effect on myocardial contractility in conscious dogs. Circ Res 81 (1997) 627-635
6. Deswal A., Petersen N.J., Feldman A.M., et al. Cytokines and cytokines receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST). Circulation 103 (2001) 2055-2059
7. Kelly R.A., and Smith T.W. Cytokines and cardiac contractile function. Circulation 95 (1997) 778-781
8. Vasan R.S., Sullivan L.M., Roubenoff R., et al. Inflammatory markers and risk of heart failure in elderly subjects without a prior myocardial infarction: the Framingham Study. Circulation 107 (2003) 1486-1491
9. Pepys M.B. CRP or not CRP? That is the question. Arterioscler Thromb Vasc Biol 25 (2005) 1091-1094
10. Ikeda U., Maeda Y., Yamamoto K., et al. C-reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Cardiovasc Res 56 (2002) 86-92
11. Sullivan D.R., Marwick T.H., and Freedman S.B. A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors. Am Heart J 119 6 (1990) 1262-1267
12. Krown K.A., Page M.T., Nguyen C., et al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest 98 (1996) 2854-2865
13. Alonso-Martínez J.L., Llorente-Diez B., Echegaray-Agara M., et al. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur J Heart Fail 4 (2002) 331-336
14. Jones S.A., Novick D., Horiuchi S., et al. C-reactive protein: a physiological activator of interleukin-6 receptor shedding. J Exp Med 189 (1999) 599-604
15. Verma S., Li S.H., Badiwala M.V., et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation 105 (2002) 1890-1896
16. Fichtlscherer S., Rosenberger G., Walter D.H., et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102 (2000) 1000-1006
17. Hambrecht R., Fiehn E., Weigl C., et al. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation (1998) 2709-2715
18. Lindahl B., Toss H., Siegbahn A., et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 343 (2000) 1139-1147
19. Arroyo-Espliguero R., Avanzas P., Cosín-Sales J., et al. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 25 (2004) 401-408
20. Anand I.S., Latini R., Florea V.G., et al. C-reactive protein in heart failure. Prognostic value and the effect of valsartan. Circulation 112 (2005) 1428-1434
21. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
22. Hartmann F., Packer M., Coats A.J., et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110 (2004) 1780-1786
23. Campbell D.J., Woodward M., Chalmers J.P., et al. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease. Hypertension 45 (2005) 69-74
24. Bettencourt P., Azevedo A., Pimenta J., et al. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
25. Parissis J.T., Adamopoulos S., Farmakis D., et al. Effects of serial levosimendan infusions on left ventricular performance and plasma biomarkers of myocardial injury and neurohormonal and immune activation in patients with advanced heart failure. Heart 92 (2006) 1768-1772
26. Krum H., and McMurray J.J. Statins and chronic heart failure: do we need a large-scale outcome trial?. J Am Coll Cardiol 39 (2002) 1567-1573
27. Go A.S., Lee W.Y., Yang J., et al. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA 296 (2006) 2105-2111
28. Bennett J.A., Riegel B., Bittner V., et al. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung 31 (2002) 262-270